MR molecular imaging of HCC employing a regulated ferritin gene carried by a modified polycation vector

References

• Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37513025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. The Lancet. 2018;391:1023–1075. doi:10.1016/S0140-6736(17)33326-3
   PubMed Web of Science ®Google Scholar
• Boehm-Sturm P, Haeckel A, Hauptmann R, et al. Low-molecular-weight iron chelates may be an alternative to gadolinium-based contrast agents for T1-weighted contrast-enhanced MR imaging. Radiology. 2018;286(2):537–546. doi:10.1148/radiol.201717011628880786
   PubMedGoogle Scholar
• Vandsburger MH, Radoul M, Addadi Y, et al. Ovarian carcinoma: quantitative biexponential MR imaging relaxometry reveals the dynamic recruitment of ferritin-expressing fibroblasts to the angiogenic rim of tumors. Radiology. 2013;268(3):790–801. doi:10.1148/radiol.1312205323801774
   PubMedGoogle Scholar
• Lee CW, Choi SI, Lee SJ, et al. The effectiveness of ferritin as a contrast agent for cell tracking MRI in mouse cancer models. Yonsei Med J. 2017;58(1):51–58. doi:10.3349/ymj.2017.58.1.5127873495
   PubMedGoogle Scholar
• Cheng S, Mi R, Xu Y, et al. Ferritin heavy chain as a molecular imaging reporter gene in glioma xenografts. J Cancer Res Clin Oncol. 2017;143:941–951. doi:10.1007/s00432-017-2356-z28247036
   PubMedGoogle Scholar
• Guo R, Li Q, Yang F, et al. In vivo MR imaging of dual MRI reporter genes and deltex-1 gene-modified human mesenchymal stem cells in the treatment of closed penile fracture. Mol Imaging Biol. 2018;20:417–427. doi:10.1007/s11307-017-1128-028971290
   PubMed Web of Science ®Google Scholar
• Yang Y, Gong M, Yang H, et al. MR molecular imaging of tumours using ferritin heavy chain reporter gene expression mediated by the hTERT promoter. Eur Radiol. 2016;26:4089–4097. doi:10.1007/s00330-016-4259-926960542
   PubMedGoogle Scholar
• Pereira S, Moss D, Williams S, Murray P, Taylor A. Overexpression of the MRI reporter genes ferritin and transferrin receptor affect iron homeostasis and produce limited contrast in mesenchymal stem cells. Int J Mol Sci. 2015;16:15481–15496.26184159
   PubMed Web of Science ®Google Scholar
• Cao M, Mao J, Duan X, et al. In vivo tracking of the tropism of mesenchymal stem cells to malignant gliomas using reporter gene-based MR imaging. Int J Cancer. 2018;142:1033–1046.29047121
   PubMed Web of Science ®Google Scholar
• Arosio P, Ingrassia R, Cavadini P. Ferritins: a family of molecules for iron storage, antioxidation and more. Biochimica et Biophys Acta (BBA) Gen Subj. 2009;1790:589–599. doi:10.1016/j.bbagen.2008.09.004
   PubMed Web of Science ®Google Scholar
• Iordanova B, Ahrens ET. In vivo magnetic resonance imaging of ferritin-based reporter visualizes native neuroblast migration. NeuroImage. 2012;59:1004–1012. doi:10.1016/j.neuroimage.2011.08.06821939774
   PubMedGoogle Scholar
• He X, Cai J, Liu B, Zhong Y, Qin Y. Cellular magnetic resonance imaging contrast generated by the ferritin heavy chain genetic reporter under the control of a Tet-On switch. Stem Cell Res Ther. 2015;6:207. doi:10.1186/s13287-015-0205-z26517988
   PubMedGoogle Scholar
• Ding WC, Guo L. Immobilized transferrin Fe3O4@SiO2 nanoparticle with high doxorubicin loading for dual-targeted tumor drug delivery. Int J Nanomedicine. 2013;8:4631–4639. doi:10.2147/IJN.S5174524348038
   PubMed Web of Science ®Google Scholar
• Shen Y, Li X, Dong DD, Zhang B, Xue YR, Shang P. Transferrin receptor 1 in cancer: a new sight for cancer therapy. Am J Cancer Res. 2018;8(6):916–931.30034931
   PubMed Web of Science ®Google Scholar
• Kim KI, Lee YJ, Lee TS, et al. In vitro radionuclide therapy and in vivo scintigraphic imaging of alpha-fetoprotein-producing hepatocellular carcinoma by targeted sodium iodide symporter gene expression. Nucl Med Mol Imaging. 2013;47:1–8.24895502
   PubMedGoogle Scholar
• Wu L, Johnson M, Sato M. Transcriptionally targeted gene therapy to detect and treat cancer. Trends Mol Med. 2003;9(10):421. doi:10.1016/j.molmed.2003.08.00514557054
   PubMed Web of Science ®Google Scholar
• Aung W, Hasegawa S, Koshikawa-Yano M, et al. Visualization of in vivo electroporation-mediated transgene expression in experimental tumors by optical and magnetic resonance imaging. Gene Ther. 2009;16:830–839. doi:10.1038/gt.2009.5519458649
   PubMed Web of Science ®Google Scholar
• Li J, Loh X. Cyclodextrin-based supramolecular architectures: syntheses, structures, and applications for drug and gene delivery. Adv Drug Deliv Rev. 2008;60:1000–1017. doi:10.1016/j.addr.2008.02.01118413280
   PubMed Web of Science ®Google Scholar
• Cryan S, Holohan A, Donohue R, Darcy R, O Driscoll CM. Cell transfection with polycationic cyclodextrin vectors. Eur JPharm Sci. 2004;21:625–633. doi:10.1016/j.ejps.2004.01.00115066663
   PubMed Web of Science ®Google Scholar
• Liu X, Chen X, Chua MX, Li Z, Loh XJ, Wu Y-L. Injectable supramolecular hydrogels as delivery agents of Bcl-2 conversion gene for the effective shrinkage of therapeutic resistance tumors. Adv Healthc Mater. 2017;6:1700159. doi:10.1002/adhm.v6.11
   Web of Science ®Google Scholar
• Ping Y, Liu C, Zhang Z, Liu KL, Chen J, Li J. Chitosan-graft-(PEI-β-cyclodextrin) copolymers and their supramolecular PEGylation for DNA and siRNA delivery. Biomaterials. 2011;32:8328–8341. doi:10.1016/j.biomaterials.2011.07.03821840593
   PubMed Web of Science ®Google Scholar
• Huang H, Yu H, Tang G, Wang Q, Li J. Low molecular weight polyethylenimine cross-linked by 2-hydroxypropyl-γ-cyclodextrin coupled to peptide targeting HER2 as a gene delivery vector. Biomaterials. 2010;31:1830–1838. doi:10.1016/j.biomaterials.2009.11.01219942284
   PubMed Web of Science ®Google Scholar
• Forrest ML, Gabrielson N, Pack DW. Cyclodextrin-polyethylenimine conjugates for targeted in vitro gene delivery. Biotechnol Bioeng. 2005;89:416–423. doi:10.1002/bit.2035615627256
   PubMed Web of Science ®Google Scholar
• Ogris M, Steinlein P, Carotta S, Brunner S, Wagner E. DNA/polyethylenimine transfection particles: influence of ligands, polymer size, and PEGylation on internalization and gene expression. AAPS PharmSci. 2001;3:E21. doi:10.1208/ps03032111741272
   PubMed Web of Science ®Google Scholar
• Li JM, Zhang W, Su H, et al. Reversal of multidrug resistance in MCF-7/Adr cells by codelivery of doxorubicin and BCL2 siRNA using a folic acid-conjugated polyethylenimine hydroxypropyl-β-cyclodextrin nanocarrier. Int J Nanomedicine. 2015;10:3147–3162. doi:10.2147/IJN.S6714625960653
   PubMed Web of Science ®Google Scholar
• Wenz G. Cyclodextrins as building blocks for supramolecular structures and functional units. Angew Chem Int Ed Engl. 1994;33:803–822. doi:10.1002/(ISSN)1521-3773
   Web of Science ®Google Scholar
• Chen Y, Yao X, Ruan G, et al. Gene-carried chitosan-linked polyethylenimine induced high gene transfection efficiency on dendritic cells. Biotechnol Appl Biochem. 2012;59:346–352. doi:10.1002/bab.103623586911
   PubMed Web of Science ®Google Scholar
• Ping Y, Hu Q, Tang G, Li J. FGFR-targeted gene delivery mediated by supramolecular assembly between β-cyclodextrin-crosslinked PEI and redox-sensitive PEG. Biomaterials. 2013;34:6482–6494. doi:10.1016/j.biomaterials.2013.03.07123602276
   PubMed Web of Science ®Google Scholar
• Chen X, Qiu YK, Owh C, Loh XJ, Wu YL. Supramolecular cyclodextrin nanocarriers for chemo- and gene therapy towards the effective treatment of drug resistant cancers. Nanoscale. 2016;8:18876–18881. doi:10.1039/c6nr08055c27819368
   PubMed Web of Science ®Google Scholar
• Neu M, Fischer D, Kissel T. Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its derivatives. J Gene Med. 2005;7:992–1009. doi:10.1002/jgm.77315920783
   PubMed Web of Science ®Google Scholar
• Cohen B, Ziv K, Plaks V, Harmelin A, Neeman M. Ferritin nanoparticles as magnetic resonance reporter gene. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2009;1:181–188. doi:10.1002/wnan.1120049789
   PubMedGoogle Scholar
• Cohen B, Ziv K, Plaks V, et al. MRI detection of transcriptional regulation of gene expression in transgenic mice. Nat Med. 2007;13:498–503. doi:10.1038/nm149717351627
   PubMed Web of Science ®Google Scholar
• Zhou Z, Tian R, Wang Z, et al. Artificial local magnetic field inhomogeneity enhances T2 relaxivity. Nat Commun. 2017;8:15468. doi:10.1038/ncomms1546828516947
   PubMedGoogle Scholar
• Pereira S, Herrmann A, Moss D, et al. Evaluating the effectiveness of transferrin receptor-1 (TfR1) as a magnetic resonance reporter gene. Contrast Media Mol Imaging. 2016;11:236–244. doi:10.1002/cmmi.168626929139
   PubMedGoogle Scholar
• Feng Y, Liu Q, Zhu J, Xie F, Li L. Efficiency of ferritin as an MRI reporter gene in NPC cells is enhanced by iron supplementation. J Biomed Biotechnol. 2012;2012:1–11. doi:10.1155/2012/72834221836813
   PubMedGoogle Scholar
• Graham RM, Reutens GM, Herbison CE, et al. Transferrin receptor 2 mediates uptake of transferrin-bound and non-transferrin-bound iron. J Hepatol. 2008;48(2):327–334. doi:10.1016/j.jhep.2007.10.00918083267
   PubMed Web of Science ®Google Scholar
• Richardson DR. Mysteries of the transferrin-transferrin receptor 1 interaction uncovered. Cell. 2004;116(4):483–485.14980214
   PubMed Web of Science ®Google Scholar
• Wang CY, Knutson MD. Hepatocyte divalent metal-ion transporter-1 is dispensable for hepatic iron accumulation and non-transferrin-bound iron uptake in mice. Hepatology. 2013;58(2):788–798. doi:10.1002/hep.2640123508576
   PubMedGoogle Scholar
• Jasanoff A. Contrast Agents for Molecular-Level fMRI In: Uludag K, Ugurbil K, Berliner L, editors. fMRI: From Nuclear Spins to Brain Functions. Biological Magnetic Resonance. Vol. 30 Boston: Springer; 2015:865–894.
   Google Scholar
• Xue S, Yang H, Qiao J, et al. Protein MRI contrast agent with unprecedented metal selectivity and sensitivity for liver cancer imaging. Proc Natl Acad Sci USA. 2015;112:6607–6612. doi:10.1073/pnas.142302111225971726
   PubMedGoogle Scholar
• Yamashita T, Kitao A, Matsui O, et al. Gd-EOB-DTPA-enhanced magnetic resonance imaging and alpha-fetoprotein predict prognosis of early-stage hepatocellular carcinoma. Hepatology. 2014;60(5):1674–1685. doi:10.1002/hep.2716324700365
   PubMedGoogle Scholar
• Midura S, Schneider E, Rosen GM, Winalski CS, Midura RJ. In vitro chondrocyte toxicity following long-term, high-dose exposure to Gd-DTPA and a novel cartilage-targeted MR contrast agent. Skeletal Radiol. 2017;46:23–33. doi:10.1007/s00256-016-2502-827815598
   PubMedGoogle Scholar
• Singh M, Mugler K, Hailoo DW, et al. Differential Expression of Transferrin Receptor (TfR) in a spectrum of normal to malignant breast tissues: implications for in situ and invasive carcinoma. Appl Immunohistochem Mol Morphol. 2011;19(5):417–423. doi:10.1097/PAI.0b013e318209716e21297444
   PubMedGoogle Scholar
• Mulik RS, Mönkkönen J, Juvonen RO, Mahadik KR, Paradkar AR. Transferrin mediated solid lipid nanoparticles containing curcumin: enhanced in vitro anticancer activity by induction of apoptosis. Int J Pharm. 2010;398(1–2):190–203. doi:10.1016/j.ijpharm.2010.07.02120655375
   PubMed Web of Science ®Google Scholar
• Han YQ, Zhang Y, Li DN, Chen YY, Sun JP, Kong FS. Transferrin-modified nanostructured lipid carriers as multifunctional nanomedicine for codelivery of DNA and doxorubicin. Int J Nanomedicine. 2014;9:4107–4116. doi:10.2147/IJN.S6777025187713
   PubMed Web of Science ®Google Scholar
• Singh RP, Sharma G, Agrawal P, Pandey BL, Koch B, Muthu MS. Transferrin receptor targeted PLA-TPGS micelles improved efficacy and safety in docetaxel delivery. Int J Biol Macromol. 2016;83:335–344. doi:10.1016/j.ijbiomac.2015.11.08126657586
   PubMed Web of Science ®Google Scholar